| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.09. | Irdeto geht Partnerschaft mit Bitmovin ein, um branchenführendes Streaming mit niedriger Latenz für großartiges Nutzererlebnis zu ermöglichen | 603 | Business Wire | Durch dieses gemeinsame Angebot können Betreiber von nahtlosem, hochwertigen Streaming profitieren. Darüber hinaus wird die Reichweite erhöht, mehr Werbung ist möglich und die Sicherheit wird verbessert.... ► Artikel lesen | |
| 14.09. | Incyte's CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer | 620 | Business Wire | New antitumor response data from a range of doses and regimens unveiled today at Incyte investor event These results build upon safety and tolerability data presented earlier today during... ► Artikel lesen | |
| 14.09. | China Dongfeng Motor Industry Imp. & Exp. Co. Ltd: Dongfeng Embarks on a New Journey in Europe, Various New Products Debuted Offer Diversified Mobility Options | 879 | Business Wire | On September 12th, Dongfeng Motor held the DONGFENG DAYS EUROPE launch event in Turin, Italy, officially announcing the entry of DONGFENG BOX into the Italian market and the first European debut of... ► Artikel lesen | |
| 14.09. | Merck & Co., Inc.: Merck's KEYTRUDA (pembrolizumab) Plus Chemoradiotherapy (CRT) Reduced Risk of Death by 33% Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer | 1.240 | Business Wire | KEYNOTE-A18 is the first Phase 3 study of an immunotherapy in combination with CRT to demonstrate a statistically significant and clinically meaningful improvement in overall survival versus CRT... ► Artikel lesen | |
| 14.09. | Incyte's Retifanlimab (Zynyz) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium | 623 | Business Wire | Phase 3 POD1UM-303/InterAACT2 trial met primary endpoint of progression-free survival and demonstrated improvement across secondary endpoints in patients with squamous cell anal carcinoma (SCAC) taking... ► Artikel lesen | |
| 14.09. | Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience | 398 | Business Wire | This joint offering allows operators to benefit from seamless, high-quality streaming, extended device reach, and advanced advertising and security features Irdeto, the global leader in digital... ► Artikel lesen | |
| 14.09. | Bicycle Therapeutics plc: Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024 | 546 | Business Wire | Updated monotherapy data for Nectin-4 targeting zelenectide pevedotin in metastatic urothelial cancer (mUC) showed a promising 45% overall response rate (ORR), 11.1 months median duration of response... ► Artikel lesen | |
| 14.09. | SCF Partners: SCF übernimmt Newpark Fluids Systems von Newpark Resources Inc. (NYSE: NR) | 568 | Business Wire | SCF Partners, Inc. ("SCF") gibt erfreut bekannt, dass es das Geschäft von Newpark Fluids Systems ("NFS"), einem führenden weltweit tätigen, reinen Lösungsanbieter für die Erdöl- und Erdgasbranche... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 9.028 |
| EVOTEC | 4.475 |
| BAYER | 3.585 |
| SUPER MICRO COMPUTER | 3.472 |
| NEL | 3.187 |
| MICROSTRATEGY | 1.848 |
| RHEINMETALL | 1.759 |
| TUI | 1.519 |
| TESLA | 1.425 |
| THYSSENKRUPP | 1.278 |
| PALANTIR TECHNOLOGIES | 1.219 |
| PORSCHE AG | 1.199 |
| VOLKSWAGEN | 1.082 |
| BIONTECH | 1.037 |
| RENK GROUP | 1.033 |
| GAMESTOP | 834 |
| COINBASE GLOBAL | 829 |
| AIXTRON SE | 791 |
| COMMERZBANK | 791 |
| DEUTSCHE BANK | 763 |
| BYD | 737 |
| MERCEDES-BENZ | 730 |
| BASF | 709 |
| AMAZON | 708 |
| SNOWFLAKE | 691 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
